Artivion To Participate In Upcoming Investor Conferences


(MENAFN- PR Newswire)

ATLANTA, Nov. 5, 2024 /PRNewswire/ --
Artivion, Inc. (NYSE: AORT ) , a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming
Stifel 2024 Healthcare conference on Tuesday, November 19, 2024, at the Lotte New York Palace. The Company's presentation is scheduled to begin at 1:15p.m. ET. A live webcast can be accessed through Artivion's website, , on the Investors page. An archived copy of the webcast will be available for 90 days on the same website.

Members of the management team will also host one-on-one meetings at the upcoming Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 21, 2024, in New York. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, .

Contacts:



Artivion

Gilmartin Group LLC

Lance A. Berry

Brian Johnston / Laine Morgan

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

[email protected]

Phone: 770-419-3355


SOURCE Artivion, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN05112024003732001241ID1108854289


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.